Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

Calanolide A well tolerated in phase I trials

Feb. 5, 1998

Continued HIV suppression requires triple drug maintenance therapy

Feb. 4, 1998

PRO-2000 gel well tolerated in phase I trial in healthy females

Feb. 4, 1998

Phase III trial compares immediate and delayed treatment with fomivirsen for CMV retinitis

Feb. 4, 1998

Strategies for purging latently infected cells in HIV-positive patients studied at NIAID

Feb. 4, 1998

Promising efficacy reported at AIDS conference for amprenavir combinations

Feb. 3, 1998

Potent antiretroviral activity shown for abacavir + protease inhibitor in HIV-positive patients

Feb. 3, 1998

Swiss Remune trials initiated

Jan. 29, 1998

PMPA reduces viral load in phase I/II

Jan. 29, 1998

Triangle reports results from phase I/II FTC trial

Jan. 29, 1998

Popular Stories

Today's news in brief
BioWorld
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...